Author

Sravya Kommineni

Novartis (Switzerland)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:CRISPR screen· 2 Research Focus:drug response / drug discovery· 2 Research Focus:variant calling· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Daniel J. Ho· 3 shared Kathleen A. WorringeriD· 3 shared Ajamete KaykasiD· 2 shared Brant K. PetersoniD· 2 shared Federica PiccioniiD· 2 shared Jana M. MitchelliD· 2 shared Joseph J. RaymondiD· 2 shared Karrie Chan· 2 shared

Activity by Year

2018-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenomics

Daniel J. Ho

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GenomicsbioRxivPreprintNov 8, 2021

Natural variation in gene expression and Zika virus susceptibility revealed by villages of neural progenitor cells

Michael F. Wells, James C. Nemesh, Sulagna Dia Ghosh…·Steven A. McCarroll

The paper identifies a common genetic variant in IFITM3 that explains most inter-individual variation in neural progenitor cell susceptibility to Zika virus using natural genetic variation and synthetic perturbations.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky

NeurosciencebioRxivPreprintNov 22, 2018

Genome-wide screens in accelerated human stem cell-derived neural progenitor cells identify Zika virus host factors and drivers of proliferation

Michael F. Wells, Max R. Salick, Federica Piccioni…·Kevin C. Eggan

16 citations

humanCRISPR screen

𝕏 PostBluesky

Molecular BiologyNature MedicinePeer-reviewedJun 8, 2018

P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells

Robert J. Ihry, Kathleen A. Worringer, Max R. Salick…·Ajamete Kaykas

This study shows that CRISPR/Cas9 induces toxicity in human pluripotent stem cells, which is dependent on TP53 and hinders genome engineering.

978 citationstop 1%

humanCRISPR screen

𝕏 PostBluesky